PATENT EXPIRY DATES 1/3 | New Drug Approvals
High-Court-Sides-Teva-Patent
Skinny labelling of generics: the beginning of the end for this practice? - Pharma Technology Focus | Issue 104 | March 2021
List - 54 Drug Patents Expiring in 2024 - GreyB
Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value
Biosimilars Law Bulletin | Rothwell Figg | Biologics and Biosimilars Practice
Generic Pharmaceuticals Market – Global Industry Size, Share, Analysis & Trends 2023-2032 | BioSpace
TEVA BRANDED PHARM drug patent status, global patents
Several blockbuster patents to expire in 2023 - BioStock
Global Generic Drugs Market Report 2022: Rapid Patent Expiry of Branded Drugs Creates Opportunities
The biggest drug patent losses for 2013 - GaBI Journal
TEVA drug pipeline, global patents
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Teva: Warren Buffett Likely Made A Mistake Selling Shares | Seeking Alpha
US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute | Reuters
TEVA PHARMS USA drug pipeline, international patents
Teva Pharmaceuticals - Wikipedia
Generics behaving badly? BMS v Teva illustrates UK judicial mood towards generic launch plans (Part I) - The IPKat
Pharmaceuticals | Free Full-Text | Biosimilars: Company Strategies to Capture Value from the Biologics Market
Patent expiry dates for biologicals: 2018 update - GaBI Journal
Sandoz and Teva invalidate blockbuster apixaban patent and SPC - JUVE Patent
Top 15 drug patent losses for 2013 | Download Table
Teva Capitalizes On Patent Expiry To Launch First Perforomist Rival :: Generics Bulletin
